HK59989A - Improvements in or relating to nasal pharmaceutical compositions - Google Patents

Improvements in or relating to nasal pharmaceutical compositions Download PDF

Info

Publication number
HK59989A
HK59989A HK599/89A HK59989A HK59989A HK 59989 A HK59989 A HK 59989A HK 599/89 A HK599/89 A HK 599/89A HK 59989 A HK59989 A HK 59989A HK 59989 A HK59989 A HK 59989A
Authority
HK
Hong Kong
Prior art keywords
relating
pharmaceutical compositions
nasal administration
nasal pharmaceutical
agent
Prior art date
Application number
HK599/89A
Other languages
English (en)
Inventor
Kiechel Jean-Rene
Plas Danielle
Acezat-Mispelter Francoise
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK59989A publication Critical patent/HK59989A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK599/89A 1982-02-01 1989-07-27 Improvements in or relating to nasal pharmaceutical compositions HK59989A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (1)

Publication Number Publication Date
HK59989A true HK59989A (en) 1989-08-04

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
HK599/89A HK59989A (en) 1982-02-01 1989-07-27 Improvements in or relating to nasal pharmaceutical compositions

Country Status (27)

Country Link
JP (1) JPS58134017A (enExample)
AT (1) AT385656B (enExample)
AU (1) AU565613B2 (enExample)
BE (1) BE895750A (enExample)
CA (1) CA1197783A (enExample)
CH (1) CH653555A5 (enExample)
DE (1) DE3302949A1 (enExample)
DK (1) DK164771C (enExample)
ES (1) ES519450A0 (enExample)
FI (1) FI81258C (enExample)
FR (1) FR2539994B1 (enExample)
GR (1) GR81320B (enExample)
HK (1) HK59989A (enExample)
HU (1) HU191512B (enExample)
IE (1) IE54532B1 (enExample)
IL (1) IL67822A (enExample)
IT (1) IT1197558B (enExample)
KE (1) KE3888A (enExample)
LU (1) LU84613A1 (enExample)
MY (1) MY8700766A (enExample)
NL (1) NL192325C (enExample)
NZ (1) NZ203117A (enExample)
PH (1) PH22198A (enExample)
PT (1) PT76166B (enExample)
SE (1) SE454402B (enExample)
SG (1) SG34389G (enExample)
ZA (1) ZA83673B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
JP7317020B2 (ja) * 2018-01-05 2023-07-28 インペル ファーマシューティカルズ インコーポレイテッド 精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
IL67822A (en) 1988-02-29
AU1085083A (en) 1983-08-11
MY8700766A (en) 1987-12-31
IT8347646A0 (it) 1983-02-01
NL192325B (nl) 1997-02-03
IT1197558B (it) 1988-12-06
FR2539994B1 (fr) 1986-10-10
ES8502865A1 (es) 1985-02-01
IL67822A0 (en) 1983-06-15
IE830187L (en) 1983-08-01
ES519450A0 (es) 1985-02-01
PT76166A (en) 1983-02-01
IT8347646A1 (it) 1984-08-01
GR81320B (enExample) 1984-12-11
SE8300495L (sv) 1983-08-02
SE8300495D0 (sv) 1983-01-31
IE54532B1 (en) 1989-11-08
NZ203117A (en) 1986-12-05
BE895750A (fr) 1983-08-01
FI81258B (fi) 1990-06-29
SG34389G (en) 1989-09-22
ATA30383A (de) 1987-10-15
NL192325C (nl) 1997-06-04
KE3888A (en) 1989-09-01
CA1197783A (en) 1985-12-10
FI81258C (fi) 1990-10-10
DK164771B (da) 1992-08-17
JPH0253406B2 (enExample) 1990-11-16
NL8300325A (nl) 1983-09-01
FR2539994A1 (fr) 1984-08-03
PT76166B (en) 1986-02-04
ZA83673B (en) 1984-09-26
HU191512B (en) 1987-02-27
FI830245A0 (fi) 1983-01-25
DK38183A (da) 1983-08-02
CH653555A5 (de) 1986-01-15
SE454402B (sv) 1988-05-02
DK164771C (da) 1992-12-28
AU565613B2 (en) 1987-09-24
AT385656B (de) 1988-05-10
PH22198A (en) 1988-06-28
JPS58134017A (ja) 1983-08-10
FI830245L (fi) 1983-08-02
DE3302949C2 (enExample) 1992-05-21
LU84613A1 (fr) 1983-09-08
DE3302949A1 (de) 1983-08-11
DK38183D0 (da) 1983-01-31

Similar Documents

Publication Publication Date Title
GB9425160D0 (en) Medicaments
NZ243061A (en) Aerosol containing a medicament and 1,1,1,2,3,3,3-heptafluoropropane
CA2277913A1 (en) New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
CA2455115A1 (en) Pharmaceutical aerosol formulation
HK27389A (en) Galenic compositions comprising calcitonin and their use
MY8600471A (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa and method for administration thereof
MY115688A (en) Pharmaceutical composition for administration by inhalation
IE870993L (en) Nasal administration compositions.
CA2628857A1 (en) Formulation and method for treating neoplasms by inhalation
AU2375188A (en) Intranasal administration of polypeptides in powdered form
PH27594A (en) Medicaments for the treatment of asthma and other respiratory disorders
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
IE872453L (en) A new system for administration of liposomes to mammals
ES8600060A1 (es) Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
WO1998013024A3 (en) Hyaluronic drug delivery system
IE800117L (en) Depot body on the basis of silicone rubber for sustained¹drug release
HUT41644A (en) Process for producing therapeutic preparation suitable for transdermic treating
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
NZ335938A (en) Prodrug forms and new analogues of camptothecin, their use as medicaments
EP0173664A3 (en) Biologically active benzimidazole compounds and process for their preparation
NZ334112A (en) Aerosol formulation comprising 1,1,1,2,3,3,3-heptafluoropropane, mometasone furoate and ethanol
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
HUP0002533A2 (hu) Asztmaellenes gyógyszerhatóanyagok új kombinációja

Legal Events

Date Code Title Description
PE Patent expired